Market revenue in 2023 | USD 14.3 million |
Market revenue in 2030 | USD 27.4 million |
Growth rate | 9.7% (CAGR from 2023 to 2030) |
Largest segment | Surgery |
Fastest growing segment | Intralesional injections |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiotherapy (RT), Intralesional injections, Intravenous Medications, Chemical peeling treatment, Surgery, Topical chemotherapy, Oral Medications |
Key market players worldwide | Bausch Health Companies Inc, Almirall SA, Genentech, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Dr Reddy's Laboratories Ltd ADR, Taro Pharmaceuticals, Accord Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to basal cell carcinoma treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 35.66% in 2023. Horizon Databook has segmented the Denmark basal cell carcinoma treatment market based on radiotherapy (rt), intralesional injections, intravenous medications, chemical peeling treatment, surgery, topical chemotherapy, oral medications covering the revenue growth of each sub-segment from 2018 to 2030.
The Denmark market for BCC treatment is experiencing growth, driven by the rising incidence of BCC, partly due to an aging population, which is a primary driver. According to data from The Danish Cancer Registry.
With 14,657 new cases registered in 2019 and a generally similar incidence rate between women and men that increases with age, the demand for effective treatments is rising. Denmark's well-established healthcare infrastructure can support the growing need for BCC treatments.
The country's high disease burden and a growing demand for noninvasive diagnostic tests can further propel the market. The government's response to the high cancer prevalence, which is the highest among women and men combined.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark basal cell carcinoma treatment market , including forecasts for subscribers. This country databook contains high-level insights into Denmark basal cell carcinoma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account